Paper36920736
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.
Leidenmühler P and 6 others. Drug Deliv Transl Res, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins. Papers, record 36920736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyaluronoglucosaminidase | Major topic |
| Immunologic Deficiency Syndromes | Major topic |
| Humans | |
| Animals | |
| Swine | |
| Immunoglobulins | |
| Infusions, Subcutaneous | |
| Injections, Subcutaneous |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21199100 | European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision. | J Peripher Nerv Syst | 2010 | https://conductscience.org/library/papers/21199100 | PubMed |
| 2 | 25787031 | Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model. | Drug Deliv Transl Res | 2012 | https://conductscience.org/library/papers/25787031 | PubMed |
| 3 | 27747583 | Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis. | Rheumatol Ther | 2016 | https://conductscience.org/library/papers/27747583 | PubMed |
| 4 | 15480339 | Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. | J Allergy Clin Immunol | 2004 | https://conductscience.org/library/papers/15480339 | PubMed |
| 5 | 6112565 | High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. | Lancet | 1981 | https://conductscience.org/library/papers/6112565 | PubMed |
| 6 | 17911466 | Intravenous immunoglobulin and autoimmune disease. | Ann N Y Acad Sci | 2007 | https://conductscience.org/library/papers/17911466 | PubMed |
| 7 | 33469268 | Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/33469268 | PubMed |
| 8 | 7540602 | A comparison of the patient-borne costs of therapy with gamma globulin given at the hospital or at home. | Int J Technol Assess Health Care | 1995 | https://conductscience.org/library/papers/7540602 | PubMed |
| 9 | 25693652 | Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects. | AAPS PharmSciTech | 2015 | https://conductscience.org/library/papers/25693652 | PubMed |
| 10 | 16783465 | Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. | J Clin Immunol | 2006 | https://conductscience.org/library/papers/16783465 | PubMed |
| 11 | 6209513 | High-dose intravenous gammaglobulin for Kawasaki disease. | Lancet | 1984 | https://conductscience.org/library/papers/6209513 | PubMed |
| 12 | 18842292 | Intravenous immunoglobulin: adverse reactions and management. | J Allergy Clin Immunol | 2008 | https://conductscience.org/library/papers/18842292 | PubMed |
| 13 | 20674834 | Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies. | Ann Allergy Asthma Immunol | 2010 | https://conductscience.org/library/papers/20674834 | PubMed |
| 14 | 19114702 | Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19114702 | PubMed |
| 15 | 18937372 | Quantitation of protein particles in parenteral solutions using micro-flow imaging. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/18937372 | PubMed |
| 16 | 1712881 | Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. | Lancet | 1991 | https://conductscience.org/library/papers/1712881 | PubMed |
| 17 | 17683255 | Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. | Expert Opin Drug Deliv | 2007 | https://conductscience.org/library/papers/17683255 | PubMed |
| 18 | 23456255 | Bioavailability of IgG administered by the subcutaneous route. | J Clin Immunol | 2013 | https://conductscience.org/library/papers/23456255 | PubMed |
| 19 | 19883424 | Subcutaneous immunoglobulin: opportunities and outlook. | Clin Exp Immunol | 2009 | https://conductscience.org/library/papers/19883424 | PubMed |
| 20 | 7513227 | Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. | Immunodeficiency | 1993 | https://conductscience.org/library/papers/7513227 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40103597 | Patient Preferences for Faster Home-Based Subcutaneous Immunoglobulin Infusion Therapy and the Effect on Adverse Events. | Patient Prefer Adherence | 2025 | https://conductscience.org/library/papers/40103597 | PubMed |
| 38129731 | A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults. | J Clin Immunol | 2023 | https://conductscience.org/library/papers/38129731 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SPAM1 | 6677 | PubTator's text mining | https://conductscience.org/library/genes/6677 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36920736
GET https://conductscience.org/api/papers/v1/36920736/references?page=2